The global orthobiologics market size is expected to reach USD 8.32 Billion in 2028 and register a revenue CAGR of 5.1% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is due to increasing use of orthobiologics in regenerative medicine that utilizes human body’s own cells and healing components to possibly reverse incapacitating impacts of osteoarthritis and helps in quick healing of ligament as well as tendon wounds. When high concentration of healing substances are injected into damaged or affected body parts, these substances can initiate quick healing process and possibly reverse weakening impacts.
Furthermore, advent of advanced technologies in the field is expected to drive revenue growth of the global orthobiologics market during forecast period. For instance, increasing adoption of 3D printed implants that help assist with improved clinical results by decreasing surgical procedure time and offer better firmness for orthopedic surgery. This technology assists in treating ligament and spinal wounds, with minimum invasions. Increasing cases of musculoskeletal disorders could lead to orthopedic procedures, which is further expected to increase demand for orthobiologics treatment.
Increasing incidence of lethal falls resulting in fractures and other accidental wounds is driving need for orthobiologics. Major manufacturers are focusing in R&D of new orthobiologics products such as viscosupplementation products to heal wounded tendons, muscles, and fractures in lesser duration.
However, inadequate medical facilities, undeveloped healthcare sector in various developing and underdeveloped countries, and lack of awareness about orthobiologics among people in underdeveloped countries are factors that can hamper market revenue growth over the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4643
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Arthrex, Bioventus, DePuy Synthes (Subsidiary of Johnson & Johnson), Globus Medical Inc., Orthofix, RTI Surgical, Sanofi-Genzyme, SeaSpine Holdings, Smith & Nephew, Stryker Corporation, Zimmer Biomet.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4643
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Orthobiologics market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Orthobiologics industry, the market is segmented into:
Product Type Outlook (Revenue, USD billion; 2018-2028)
- Viscosupplementation Products
- Demineralized Bone Materials
- Synthetic Orthobiologics
- Bone Morphogenic
- Plasma-Rich Protein
- Bone Marrow Aspirate Concentrate
Application Outlook (Revenue, USD billion; 2018-2028)
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Soft-Tissue Injuries
- Fracture Recover and Reconstructive Surgery
- Maxillofacial and Dental Applications
End Use (Revenue, USD billion; 2018-2028)
- Orthopedic Clinics
- Research & Academic Institutes
- Dental Clinic and Facilities
- Ambulatory Care Centers
The regional analysis covers:
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/orthobiologics-market
Benefits of Orthobiologics Market Report:
- Panoramic overview of the opportunities and risks in the Orthobiologics sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Orthobiologics industry
- In-depth assessment of the competitive landscape of the key players of the Orthobiologics industry
- Analysis of the Orthobiologics market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370